Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Impact of moderate to severe mitral stenosis in patients undergoing transcatheter aortic valve replacement.

Fischer Q, Himbert D, Bernier M, Urena M, Nunes Ferreira-Neto A, Paradis JM, Mohammadi S, Iung B, Rodés-Cabau J.

Int J Cardiol. 2019 Jul 1;286:36-42. doi: 10.1016/j.ijcard.2019.03.053. Epub 2019 Mar 28.

PMID:
30967274
2.

Impact of transcatheter aortic valve replacement on hemodynamic status in patients with aortic stenosis and mitral stenosis: Doppler echocardiographic study.

Kato N, Shibayama K, Omori N, Hoshina M, Makihara Y, Okumura H, Tabata M, Obunai K, Hirao K, Pellikka PA, Watanabe H.

J Cardiol. 2019 Jun 27. pii: S0914-5087(19)30149-2. doi: 10.1016/j.jjcc.2019.05.010. [Epub ahead of print]

PMID:
31256928
3.

Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.

Joseph L, Bashir M, Xiang Q, Yerokun BA, Matsouaka RA, Vemulapalli S, Kapadia S, Cigarroa JE, Zahr F.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):693-702. doi: 10.1016/j.jcin.2018.01.245.

4.

Association of Structural and Functional Cardiac Changes With Transcatheter Aortic Valve Replacement Outcomes in Patients With Aortic Stenosis.

Fukui M, Gupta A, Abdelkarim I, Sharbaugh MS, Althouse AD, Elzomor H, Mulukutla S, Lee JS, Schindler JT, Gleason TG, Cavalcante JL.

JAMA Cardiol. 2019 Mar 1;4(3):215-222. doi: 10.1001/jamacardio.2018.4830.

PMID:
30725109
5.

Degenerative mitral regurgitation predicts worse outcomes in patients undergoing transcatheter aortic valve replacement.

Kindya B, Ouzan E, Lerakis S, Gonen E, Babaliaros V, Karayel E, Thourani VH, Gotsman I, Devireddy CM, Danenberg HD, Leshnower BG, Beeri R, Ko YA, Gilon D, Ahmed H, Liu C, Lotan C, Mavromatis K.

Catheter Cardiovasc Interv. 2018 Sep 1;92(3):574-582. doi: 10.1002/ccd.27607. Epub 2018 Mar 30.

PMID:
29602220
6.

The impact of mitral stenosis on outcomes of aortic valve stenosis patient undergoing surgical aortic valve replacement or transcatheter aortic valve replacement.

Al-Khadra Y, Darmoch F, Baibars M, Kaki A, Fanari Z, Alraies MC.

J Interv Cardiol. 2018 Oct;31(5):655-660. doi: 10.1111/joic.12519. Epub 2018 May 17.

PMID:
29774601
7.

Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR.

Alushi B, Beckhoff F, Leistner D, Franz M, Reinthaler M, Stähli BE, Morguet A, Figulla HR, Doenst T, Maisano F, Falk V, Landmesser U, Lauten A.

JACC Cardiovasc Imaging. 2019 Apr;12(4):591-601. doi: 10.1016/j.jcmg.2018.02.015. Epub 2018 Apr 18.

PMID:
29680341
8.

Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.

Barbanti M, Webb JG, Hahn RT, Feldman T, Boone RH, Smith CR, Kodali S, Zajarias A, Thompson CR, Green P, Babaliaros V, Makkar RR, Szeto WY, Douglas PS, McAndrew T, Hueter I, Miller DC, Leon MB; Placement of Aortic Transcatheter Valve Trial Investigators.

Circulation. 2013 Dec 24;128(25):2776-84. doi: 10.1161/CIRCULATIONAHA.113.003885. Epub 2013 Oct 23.

PMID:
24152861
9.

Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.

Jerez-Valero M, Urena M, Webb JG, Tamburino C, Munoz-Garcia AJ, Cheema A, Dager AE, Serra V, Amat-Santos IJ, Barbanti M, Immè S, Alonso Briales JH, Al Lawati H, Benitez LM, Cucalon AM, Garcia del Blanco B, Revilla A, Dumont E, Barbosa Ribeiro H, Nombela-Franco L, Bergeron S, Pibarot P, Rodés-Cabau J.

JACC Cardiovasc Interv. 2014 Sep;7(9):1022-32. doi: 10.1016/j.jcin.2014.04.012. Erratum in: JACC Cardiovasc Interv. 2014 Oct;7(10):1204.

10.

Transcatheter aortic valve replacement in patients with concomitant mitral stenosis.

Asami M, Windecker S, Praz F, Lanz J, Hunziker L, Rothenbühler M, Räber L, Roost E, Stortecky S, Pilgrim T.

Eur Heart J. 2019 May 1;40(17):1342-1351. doi: 10.1093/eurheartj/ehy834.

PMID:
30596992
11.

Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis and Mitral Regurgitation.

Mavromatis K, Thourani VH, Stebbins A, Vemulapalli S, Devireddy C, Guyton RA, Matsouaka R, Ghasemzadeh N, Block PC, Leshnower BG, Stewart JP, Rumsfeld JS, Lerakis S, Babaliaros V.

Ann Thorac Surg. 2017 Dec;104(6):1977-1985. doi: 10.1016/j.athoracsur.2017.05.065. Epub 2017 Sep 29.

PMID:
28965619
12.

Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The TOPAS-TAVI Registry.

Ribeiro HB, Lerakis S, Gilard M, Cavalcante JL, Makkar R, Herrmann HC, Windecker S, Enriquez-Sarano M, Cheema AN, Nombela-Franco L, Amat-Santos I, Muñoz-García AJ, Garcia Del Blanco B, Zajarias A, Lisko JC, Hayek S, Babaliaros V, Le Ven F, Gleason TG, Chakravarty T, Szeto WY, Clavel MA, de Agustin A, Serra V, Schindler JT, Dahou A, Puri R, Pelletier-Beaumont E, Côté M, Pibarot P, Rodés-Cabau J.

J Am Coll Cardiol. 2018 Mar 27;71(12):1297-1308. doi: 10.1016/j.jacc.2018.01.054.

13.

Impact of baseline mitral regurgitation on short- and long-term outcomes following transcatheter aortic valve replacement.

Kiramijyan S, Magalhaes MA, Koifman E, Didier R, Escarcega RO, Minha S, Baker NC, Negi SI, Torguson R, Gai J, Okubagzi P, Asch FM, Gaglia MA Jr, Ben-Dor I, Satler LF, Pichard AD, Waksman R.

Am Heart J. 2016 Aug;178:19-27. doi: 10.1016/j.ahj.2016.03.020. Epub 2016 Apr 19.

PMID:
27502848
14.

Prevalence and impact of preoperative moderate/severe tricuspid regurgitation on patients undergoing transcatheter aortic valve replacement.

Barbanti M, Binder RK, Dvir D, Tan J, Freeman M, Thompson CR, Cheung A, Wood DA, Leipsic J, Webb JG.

Catheter Cardiovasc Interv. 2015 Mar;85(4):677-84. doi: 10.1002/ccd.25512. Epub 2014 Apr 30.

PMID:
24740834
15.

Impact of Functional Versus Organic Baseline Mitral Regurgitation on Short- and Long-Term Outcomes After Transcatheter Aortic Valve Replacement.

Kiramijyan S, Koifman E, Asch FM, Magalhaes MA, Didier R, Escarcega RO, Negi SI, Baker NC, Jerusalem ZD, Gai J, Torguson R, Okubagzi P, Wang Z, Shults CC, Ben-Dor I, Corso PJ, Satler LF, Pichard AD, Waksman R.

Am J Cardiol. 2016 Mar 1;117(5):839-46. doi: 10.1016/j.amjcard.2015.11.064. Epub 2015 Dec 13.

PMID:
26873331
16.

Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry.

Hira RS, Vemulapalli S, Li Z, McCabe JM, Rumsfeld JS, Kapadia SR, Alam M, Jneid H, Don C, Reisman M, Virani SS, Kleiman NS.

JAMA Cardiol. 2017 Aug 1;2(8):846-854. doi: 10.1001/jamacardio.2017.1685.

17.

Late cardiac death in patients undergoing transcatheter aortic valve replacement: incidence and predictors of advanced heart failure and sudden cardiac death.

Urena M, Webb JG, Eltchaninoff H, Muñoz-García AJ, Bouleti C, Tamburino C, Nombela-Franco L, Nietlispach F, Moris C, Ruel M, Dager AE, Serra V, Cheema AN, Amat-Santos IJ, de Brito FS, Lemos PA, Abizaid A, Sarmento-Leite R, Ribeiro HB, Dumont E, Barbanti M, Durand E, Alonso Briales JH, Himbert D, Vahanian A, Immè S, Garcia E, Maisano F, del Valle R, Benitez LM, García del Blanco B, Gutiérrez H, Perin MA, Siqueira D, Bernardi G, Philippon F, Rodés-Cabau J.

J Am Coll Cardiol. 2015 Feb 10;65(5):437-48. doi: 10.1016/j.jacc.2014.11.027.

18.

Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation.

Toggweiler S, Boone RH, Rodés-Cabau J, Humphries KH, Lee M, Nombela-Franco L, Bagur R, Willson AB, Binder RK, Gurvitch R, Grewal J, Moss R, Munt B, Thompson CR, Freeman M, Ye J, Cheung A, Dumont E, Wood DA, Webb JG.

J Am Coll Cardiol. 2012 Jun 5;59(23):2068-74. doi: 10.1016/j.jacc.2012.02.020. Epub 2012 Apr 4.

19.

Prognostic Importance of Diastolic Dysfunction in Relation to Post Procedural Aortic Insufficiency in Patients Undergoing Transcatheter Aortic Valve Replacement.

Kampaktsis PN, Bang CN, Chiu Wong S, Skubas NJ, Singh H, Voudris K, Baduashvili A, Pastella K, Swaminathan RV, Kaple RK, Minutello RM, Feldman DN, Kim L, Hriljac I, Lin F, Bergman GS, Salemi A, Devereux RB.

Catheter Cardiovasc Interv. 2017 Feb 15;89(3):445-451. doi: 10.1002/ccd.26582. Epub 2016 May 24.

PMID:
27218599
20.

Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement.

Chamandi C, Barbanti M, Munoz-Garcia A, Latib A, Nombela-Franco L, Gutiérrez-Ibanez E, Veiga-Fernandez G, Cheema AN, Cruz-Gonzalez I, Serra V, Tamburino C, Mangieri A, Colombo A, Jiménez-Quevedo P, Elizaga J, Laughlin G, Lee DH, Garcia Del Blanco B, Rodriguez-Gabella T, Marsal JR, Côté M, Philippon F, Rodés-Cabau J.

JACC Cardiovasc Interv. 2018 Feb 12;11(3):301-310. doi: 10.1016/j.jcin.2017.10.032.

Supplemental Content

Support Center